Failure of chronic treatment with abecarnil to induce contingent and noncontingent tolerance in pentylenetetrazol-kindled rats

Epilepsia

Volumn 37, Issue 4, 1996, Pages 332-335

  Serra, M ^a,b   Ghiani, C A ^a   Maciocco, E ^a   Pisu, M G ^a   Tuligi, G ^a   Porceddu, M L ^a   Biggio, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Department of Experimental Biology ^*  (Italy)

Author keywords

Abecarnil; Contingent tolerance; Kindling; Pharmacological tolerance; Rats

Indexed keywords

ABECARNIL; PENTETRAZOLE;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MAINTENANCE THERAPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT FAILURE;

ANIMALS; ANTICONVULSANTS; CARBOLINES; DRUG TOLERANCE; EPILEPSY; INJECTIONS, INTRAPERITONEAL; KINDLING, NEUROLOGIC; MALE; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA;

EID: 0030010475     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00568.x     Document Type: Article

References (20)

1. Porter RJ. Antiepileptic drugs: efficacy and inadequacy. In: Meldrum BS, Porter RJ, eds. New anticonvulsant drugs, London: John Libbey, 1986:3-18.
2. Stephens DN, Scheider HH, Kehr W, et al. Abecarnil, a metabolically stable, anxioselective β-carboline acting at benzodiacepine receptors. J Pharmacol Exp Ther 1990;253:334-43.
3. A receptor complex after in vivo administration of the anxioselective and anticonvulsant β-carboline abecarnil. J Pharmacol Exp Ther 1992;263:1360-8.
4. A receptor subtypes. J Pharmacol Exp Ther 1993;266:385-91.
5. Löscher W, Honack D, Scherkl R, Hashem A, Frey HH. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the β-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs. J Pharmacol Exp Ther 1990;255:541-8.
6. Serra M, Ghiani CA, Motzo C, Porceddu ML, Biggio G. Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam. Pharmacol Biochem Behav 1995;52:249-54.
7. Löscher W, Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 1994;17:95-134.
8. Carlton PL, Wolgin DL. Contingent tolerance to the anorexigenic effects of amphetamine. Physiol Behav 1971;7:221-3.
9. Mana MJ, Kim CK, Pinel JPJ, Jones CH. Contingent tolerance to the anticonvulsant effects of carbamazepine, diazepam, and sodium valproate in kindled rats. Pharmacol Biochem Behav 1991;41:121-6.
10. Löscher W, Rundfeldt C. Development of tolerance to clobazam in fully kindled rats: effects of intermittent flumazenil administration. Eur J Pharmacol 1990;180:255-71.
11. Löscher W, Rundfeldt C, Hönack D. Tolerance to the anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning. Eur J Pharmacol 1991;202:303-10.
12. Turski L, Stephens DN, Jensen LH, et al. Anticonvulsant action of the β-carboline abecarnil: studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 1990;253:344-52.
13. Ozawa M, Sugimachi K, Nakada-Kometani Y, Akai T, Yamaguchi M. Chronic pharmacological activities of the novel anxiotytic β-carboline abecarnil in rats. J Pharmacol Exp Ther 1994;269:457-62.
14. Stephens DN, Weidmann R. Blockade of FG 7142 kindling by anticonvulsants acting at sites distant from the benzodiazepine receptor Brain Res 1989;492:89-98.
15. Pinel JPJ, Colbourne B, Sigalet JP, Renfrey G. Learned tolerance to the anticonvulsant effect of alcohols in rats. Pharmacol Biochem Behav 1983;18:507-10.
16. Pinel JPJ, Kim CK, Paul DJ, Mana MJ. Contingent tolerance and cross tolerance to anticonvulsant drug effects: pentobarbital and ethanol. Psychobiology 1989;17:165-70.
17. A receptor subunit mRNA levels in dentate gyrus granule cells following recurrent kindling-induced seizures. Mol Brain Res 1994;23:323-32.
18. A and glutamate receptor subunit mRNA in cortex of mice chemically kindled with FG 7142. Mol Brain Res 1994;22:320-2.
19. Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988;2:145-81.
20. Löscher W, Rundfeldt C, Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res 1993;15:207-20.